Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Marts 2019

Planlagt Fastgjort Låst Flyttet Genmab
1.2k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • S Offline
    S Offline
    Sukkeralf
    wrote on sidst redigeret af
    #969

    Just a moment...

    favicon

    (www.firstwordpharma.com)

    1 Reply Last reply
    0
    • P Offline
      P Offline
      Parasitism
      wrote on sidst redigeret af
      #970

      God morgen 🙂

      1 Reply Last reply
      0
      • J Offline
        J Offline
        JohnW
        wrote on sidst redigeret af
        #971

        Investtech: Genmab har brudt op gennem loftet i en faldende trendkanal på mellemlang sigt. Dette indikerer i første omgang svagere faldende takt, eller indledning til en mere horisontal udvikling. Aktien gav købssignal fra en omvendt-hovede-og-skuldre-formation ved bruddet op gennem modstanden ved 1103. Videre stigning til 1571 eller mere er signaleret. Aktien nærmer sig støtten ved cirka 1110 kroner, noget der kan give en reaktion op. Aktien anses samlet set teknisk positiv på mellemlang sigt.

        1 Reply Last reply
        0
        • J Offline
          J Offline
          JohnW
          wrote on sidst redigeret af
          #972

          Anbefaling: Køb

          1 Reply Last reply
          0
          • T Offline
            T Offline
            transalp
            wrote on sidst redigeret af
            #973

            Go morgen 🙂

            1 Reply Last reply
            0
            • L Offline
              L Offline
              lahn1
              wrote on sidst redigeret af
              #974

              07:11 - godt de har styr på det

              1 Reply Last reply
              0
              • J Offline
                J Offline
                Jazzz
                wrote on sidst redigeret af
                #975

                Ikke en hel skidt dag at have NOVO, Genmab og Zealand aktier..

                1 Reply Last reply
                0
                • J Offline
                  J Offline
                  JKY_VH
                  wrote on sidst redigeret af
                  #976

                  Jep, det er bedre end B&O

                  1 Reply Last reply
                  0
                  • H Offline
                    H Offline
                    HTH
                    wrote on sidst redigeret af
                    #977

                    Genmab Announces Submission of Supplemental Biologics License Application to FDA for Daratumumab in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma

                    1 Reply Last reply
                    0
                    • BulderB Offline
                      BulderB Offline
                      Bulder
                      wrote on sidst redigeret af
                      #978

                      Tilsyneladende ikke RTOR for Cass.

                      1 Reply Last reply
                      0
                      • S Offline
                        S Offline
                        Sukkeralf
                        wrote on sidst redigeret af
                        #979

                        Nu er det også en kombination der bruges i Europa, så heller ikke forventet at få RTOR på den

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #980

                          great. let's hope european application can follow soon so we can get to the transplant eligible patients

                          1 Reply Last reply
                          0
                          • T Offline
                            T Offline
                            transalp
                            wrote on sidst redigeret af
                            #981

                            Go morgen.. 🙂

                            1 Reply Last reply
                            0
                            • BulderB Offline
                              BulderB Offline
                              Bulder
                              wrote on sidst redigeret af
                              #982

                              Novatis Mayzent : https://www.reuters.com/article/us-fda-mayzent/novartis-gets-u-s-approval-for-new-drug-to-treat-multiple-sclerosis-idUSKCN1R8019

                              1 Reply Last reply
                              0
                              • BulderB Offline
                                BulderB Offline
                                Bulder
                                wrote on sidst redigeret af
                                #983

                                Link Preview Image
                                Novartis receives FDA approval for Mayzent® (siponimod), the first oral drug to treat secondary progressive MS with active disease

                                favicon

                                Novartis (www.novartis.com)

                                1 Reply Last reply
                                0
                                • B Offline
                                  B Offline
                                  bibob
                                  wrote on sidst redigeret af
                                  #984

                                  Også Celgene i MS. Der er kamp om det. https://m.firstwordpharma.com/hot-heels-eu-application-celgene-files-us-clearance-ozanimod-relapsing-multiple-sclerosis

                                  1 Reply Last reply
                                  0
                                  • P Offline
                                    P Offline
                                    Parasitism
                                    wrote on sidst redigeret af
                                    #985

                                    God morgen 🙂

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #986

                                      from recent Conference, Tisotumab vedotin
                                      https://www.mdedge.com/hematology-oncology/article/197472/gynecologic-cancer/tisotumab-vedotin-shows-promise-recurrent

                                      1 Reply Last reply
                                      0
                                      • P Offline
                                        P Offline
                                        polle1
                                        wrote on sidst redigeret af
                                        #987

                                        Godmorgen og god dag

                                        1 Reply Last reply
                                        0
                                        • B Offline
                                          B Offline
                                          bibob
                                          wrote on sidst redigeret af
                                          #988

                                          @pensionisten. Jeg håber at din kone må få nye og bedre behandlingsmuligheder. Der kommer heldigvis nye og forhåbentlig bedre medicin på markedet. Held og lykke. 🙂

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger